Browsing: Bio Tech & Pharma
Amgen announced the presentation of new data on IMDELLTRA TM (tarlatamab-dlle), a first-in-class delta-like ligand 3 (DLL3)-targeting Bispecific T-cell Engager…
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) has successfully closed a non-brokered private placement, issuing 6,000,000 common shares at $0.25…
During the pandemic, there was a noticeable disparity in healthcare outcomes, particularly for patients of color in comparison to their…
Amgen has announced the approval of a new oral treatment option for children and adolescents with moderate to severe plaque…
BCAL has initiated operations in the United States, expanding its presence into the American market.
Radiopharm Ventures has announced that RAD has increased its ownership stake in the company to 75%. This move demonstrates RAD’s…
CLEO, a renowned healthcare organization, has chosen several clinical trial sites located in the United States. These selected sites will…
In discussing the complexities of IgA nephropathy, Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University…
The proceeds from the Third Tranche will be used for the development of the Company’s Murdock Property and for general…
Professor Dana Rizk, an Investigator and member of the APPLAUSE-IgAN Steering Committee, as well as a professor at the University…